Notice of Change: Early Expiration of PAR-25-326 Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
National Institutes of Health (NIH)
Free. Verify your email, then we send one reminder only.
- Posted
- Mar 13, 2026
- Closes
- No deadline published by the funder
Amount
Amount not published by the funder
About this opportunity
National Institute of Neurological Disorders and Stroke (NINDS) The purpose of this notice is to inform the extramural community that, effective immediately, the following NOFO is expired: PAR-25-326: Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed). No further applications will be accepted for PAR-25-326. Applicants interested in applying to the Ultra-rare Gene-based Therapy (URGenT) program are encouraged to continue applying to the following NOFO: PAR-25-327: Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) National Institute of Neurological Disorders and Stroke (NINDS)